Table 1 General characteristics of study population according to initial clinical stage
Characteristics | Infection without sepsis | Sepsis | Severe sepsis | Shock |
|---|---|---|---|---|
(n = 136) | (n = 575) | (n = 1576) | (n = 394) | |
Age* | 48.5 ± 20.4 | 49.3 ± 20.5 | 57.3 ± 20.1 | 57.2 ± 20.2 |
Male sex† | 70 (51.5) | 258 (44.9) | 789 (50.1) | 199 (50.5) |
Community-acquired infection† | 100 (73.5) | 377 (65.6) | 1120 (71.1) | 249 (63.2) |
Urinary tract infection† | 42 (31.0) | 120 (20.9) | 369 (23.4) | 40 (10) |
Pneumonia† | 9 (6.6) | 101 (17.6) | 417 (26.4) | 116 (29.4) |
Intra-abdominal infection† | 4 (2.9) | 27 (4.7) | 161 (10.2) | 65 (16.5) |
Skin and soft tissues† | 40 (29) | 116 (20) | 183 (11.6) | 35 (8) |
Trauma or surgery† | 42 (30.9) | 176 (30.6) | 396 (25.1) | 150 (38.1) |
No comorbidities† | 67 (49.3) | 210 (36.5) | 510 (32.4) | 92 (23.4) |
SOFA* | 0.6 ± 0.8 | 1.2 ± 1.2 | 3.9 ± 2.4 | 8.0 ± 3.5 |
APACHE II* | 4.4 ± 3.7 | 7.3 ± 4.9 | 12.4 ± 6.2 | 17.3 ± 6.7 |
Hospital stay‡ | 5 (2 – 39) | 8 (1 – 77) | 10 (1 – 79) | 12 (1 – 74) |
28-day mortality† | 3 (2.2) | 47 (8.2) | 276 (17.6) | 172 (43.6) |